- Home
- ARGX vs SLF Comparison
ARGX vs SLF Comparison
Compare ARGX & SLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARGX
- SLF
- Stock Information
- Founded
- ARGX 2008
- SLF 1871
- Country
- ARGX Netherlands
- SLF Canada
- Employees
- ARGX N/A
- SLF N/A
- Industry
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- SLF Advertising
- Sector
- ARGX Health Care
- SLF Consumer Discretionary
- Exchange
- ARGX Nasdaq
- SLF Nasdaq
- Market Cap
- ARGX 37.3B
- SLF 33.7B
- IPO Year
- ARGX 2017
- SLF N/A
- Fundamental
- Price
- ARGX $640.52
- SLF $58.89
- Analyst Decision
- ARGX Strong Buy
- SLF
- Analyst Count
- ARGX 20
- SLF 0
- Target Price
- ARGX $653.11
- SLF N/A
- AVG Volume (30 Days)
- ARGX 258.1K
- SLF 401.3K
- Earning Date
- ARGX 02-27-2025
- SLF 02-12-2025
- Dividend Yield
- ARGX N/A
- SLF 4.06%
- EPS Growth
- ARGX N/A
- SLF 2.59
- EPS
- ARGX N/A
- SLF 4.52
- Revenue
- ARGX $1,908,659,000.00
- SLF $24,100,817,933.00
- Revenue This Year
- ARGX $70.98
- SLF N/A
- Revenue Next Year
- ARGX $51.22
- SLF $5.67
- P/E Ratio
- ARGX N/A
- SLF $12.87
- Revenue Growth
- ARGX 85.56
- SLF 5.55
- 52 Week Low
- ARGX $349.86
- SLF $46.41
- 52 Week High
- ARGX $678.21
- SLF $62.85
- Technical
- Relative Strength Index (RSI)
- ARGX 52.90
- SLF 48.49
- Support Level
- ARGX $657.10
- SLF $56.80
- Resistance Level
- ARGX $678.21
- SLF $59.66
- Average True Range (ATR)
- ARGX 15.00
- SLF 0.75
- MACD
- ARGX 0.45
- SLF 0.03
- Stochastic Oscillator
- ARGX 42.20
- SLF 67.69
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.
About SLF Sun Life Financial Inc.
Sun Life provides life insurance, retirement, and asset management products to individuals and corporate customers in Canada, the United States, and Asia. The company's investment management business contributes approximately 30% of its adjusted earnings and has around CAD 1 trillion in assets under management as of the fourth quarter of 2023. The Canada business contributes about 35% of adjusted earnings and provides individual life and health insurance, group insurance, retirement services, and wealth management solutions. The U.S. business contributed approximately 22% of earnings and is mainly focused on providing group insurance products and managing the in-force life insurance policies. Finally, the Asia segment contributes around 13% of earnings.